Abstract
Journal of Viral HepatitisVolume 18, Issue 11 p. 820-820 LETTER TO THE EDITOR Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus (J Viral Hepat 2010 Feb 1;17(2):123–9) P. Thurairajah, P. Thurairajah Liver Unit, Queen Elizabeth University Hospital, Edgbaston, BirminghamE-mail: prem.thurairajah@pms.ac.ukSearch for more papers by this authorA. Khanna, A. Khanna Liver Unit, Queen Elizabeth University Hospital, Edgbaston, BirminghamE-mail: prem.thurairajah@pms.ac.ukSearch for more papers by this authorD. Mutimer, D. Mutimer Liver Unit, Queen Elizabeth University Hospital, Edgbaston, BirminghamE-mail: prem.thurairajah@pms.ac.ukSearch for more papers by this author P. Thurairajah, P. Thurairajah Liver Unit, Queen Elizabeth University Hospital, Edgbaston, BirminghamE-mail: prem.thurairajah@pms.ac.ukSearch for more papers by this authorA. Khanna, A. Khanna Liver Unit, Queen Elizabeth University Hospital, Edgbaston, BirminghamE-mail: prem.thurairajah@pms.ac.ukSearch for more papers by this authorD. Mutimer, D. Mutimer Liver Unit, Queen Elizabeth University Hospital, Edgbaston, BirminghamE-mail: prem.thurairajah@pms.ac.ukSearch for more papers by this author First published: 05 November 2010 https://doi.org/10.1111/j.1365-2893.2010.01388.xCitations: 2Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume18, Issue11November 2011Pages 820-820 RelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
